Status:

TERMINATED

Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis

Lead Sponsor:

Astellas Pharma Global Development, Inc.

Conditions:

Candidiasis

Eligibility:

All Genders

48-120 years

Phase:

PHASE3

Brief Summary

The study will evaluate how effective and how safe the drug micafungin is when compared to the drug amphotericin B deoxycholate in treating neonates and young infants with certain fungal infections.

Detailed Description

Neonates and young infants will be stratified by estimated gestational age and by world region

Eligibility Criteria

Inclusion

  • Infant greater than 48 hours of life after birth up to day of life 120 at the time of culture acquisition
  • Diagnosis of proven invasive candidiasis within 4 days prior to study start
  • Subject's parent or legal guardian agrees not to allow subject to participate in another study with another investigational drug while on treatment.

Exclusion

  • Infant with any history of a hypersensitivity or severe vasomotor reaction to any echinocandin or systemic amphotericin B product
  • Infant who has received more than 48 hours of systemic antifungal therapy prior to the first dose of study drug
  • Infant who has a breakthrough systemic fungal infection while receiving amphotericin B product or an echinocandin as prophylaxis
  • Infant who has failed prior systemic antifungal therapy for this episode of invasive candidiasis
  • Infant who is co-infected with a non-Candida fungal organism
  • Infant whose positive yeast cultures are solely from an indwelling bladder catheter (unless obtained at the time the indwelling catheter was placed) or sputum.
  • Infant previously enrolled in this study

Key Trial Info

Start Date :

February 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2014

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT00815516

Start Date

February 1 2013

End Date

December 1 2014

Last Update

November 4 2015

Active Locations (17)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 5 (17 locations)

1

Children's Hospital of Orange County

Orange, California, United States, 92868

2

UMDNJ/Robert Wood Johnson Medical School

New Brunswick, New Jersey, United States, 08901

3

Duke University

Durham, North Carolina, United States, 27710

4

WakeMed Health and Hospitals

Raleigh, North Carolina, United States, 27610